Connect Sign In
Atypical cell-free DNA results frequently indicate clinically relevant diagnoses and offer important clues for follow-up diagnostic testing.
A newly published epidemiologic study provides evidence for a previously unrecognized transfusion risk for patients with alpha-gal syndrome, an allergic condition that can develop after a tick bite.
ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable results, insights, and answers to complex diagnostic questions. Explore solutions with us at AMLI 2026.
The study, published in the Journal of Clinical Microbiology, highlights the increased sensitivity and advantages of AI-based screening compared with manual microscopy.
Join ARUP experts at the American Society for Microbiology (ASM) Microbe 2026 conference for their latest research presentations, topic deep dives, and more.
Connect with ARUP experts to learn about our comprehensive neurology testing suites and how intentional lab testing can support clinically meaningful insights across a range of neurologic conditions.
Kanako Yumioka’s journey from Housekeeping to Specimen Processing shows how mentorship, support, and a “warmful” culture help employees grow and find their path at ARUP Laboratories.
Tracy George, MD, is a champion for patients with rare and undiagnosed conditions and will speak about ARUP’s innovative efforts that support the rare disease community.
ARUP’s Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating next generation diagnostics from concept to commercialization.
ARUP scientists authored more than 130 peer-reviewed publications and presented at over 100 conferences in 2025, highlighting a year of research, innovation, and progress in diagnostic medicine.
